Verastem Inc

Research Verastem Inc (VSTM) on Bullrun: market cap USD 335.68M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVSTM
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 335.68M
• Financial periodFY2025
• RevenueUSD 30.91M
• Revenue growth209.1%
• Net income-USD 209.47M

Valuation Snapshot

latest market cap is USD 335.68M.

About Verastem Inc

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers;

Frequently asked questions

What is Verastem Inc's market cap?

Verastem Inc's market capitalization is USD 335.68M.

What does Verastem Inc do?

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.